Related Experiment Videos
Structural features important for sigma 1 receptor binding
R A Glennon1, S Y Ablordeppey, A M Ismaiel
1Department of Medicinal Chemistry, School of Pharmacy, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0540.
Journal of Medicinal Chemistry
|April 15, 1994
Summary
Researchers developed superpotent sigma 1 ligands using N-substituted phenylalkylamines. This research addresses challenges in sigma receptor studies by providing high-affinity agents and a binding model for sigma 1 sites.
Area of Science:
- Pharmacology
- Neuroscience
- Medicinal Chemistry
Background:
- Sigma receptor research is hindered by a lack of high-affinity agents.
- Multiple sigma receptor populations (sigma 1 and sigma 2) have been identified.
- Superpotent sigma ligands (Ki < 1 nM) are crucial for advancing research.
Purpose of the Study:
- To investigate structure-affinity relationships of N-substituted phenylalkylamines at sigma 1 receptors.
- To identify novel superpotent sigma 1 ligands.
- To develop a binding model for phenylalkylamine interactions with sigma 1 sites.
Main Methods:
- Synthesis and characterization of N-substituted phenylalkylamine derivatives.
- Radioligand binding assays to determine affinity (Ki values) for sigma 1 receptors.
- Development of a computational binding model based on structure-activity relationships.
Main Results:
- Several N-substituted phenylalkylamine derivatives exhibited high affinity for sigma 1 receptors.
- Identified novel superpotent sigma 1 ligands with Ki values below 1 nM.
- Established key structural features of phenylalkylamines critical for sigma 1 receptor binding.
Conclusions:
- N-substituted phenylalkylamines represent a promising class of compounds for developing superpotent sigma 1 ligands.
- The developed binding model provides insights into the molecular interactions at sigma 1 sites.
- This work contributes significantly to the field of sigma receptor pharmacology and drug discovery.